Deborah Fassl

6505--Glipizide Tablets

The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted, HUBZone Small Business set-aside contract for the supply of Glipizide Tablets in 5mg and 10mg strengths. This procurement supports the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The contract mandates strict packaging and labeling standards. Supplies must be provided in non-glass, cylindrical bottles with a minimum 120cc volume and a 5.75-inch circumference, featuring safety caps that are either convertible or deshellable. Each product must have a unique 11-digit NDC number and a label measuring 5.25 by 2 inches. Barcoding must conform to GS1-128 or HIBC standards and include a two-dimensional data matrix as required by the Drug Supply Chain Security Act. Offerors must certify that products have passed stability testing and are compatible with automated dispensing units such as Baxter ATC Canisters and Optifill. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards. Proposals must include pricing for the base and all option years, inclusive of a 0.5 percent cost recovery fee. Offerors who are not the manufacturer must provide a Letter of Commitment to ensure a consistent supply. Following Amendment 0001, the final deadline for submission of offers via email to the designated contract specialists is October 8, 2026, at 2:30 PM CT.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Sep 18, 2026

36E79726R0031_1

Closed

Federal3

6505--2027-2028 Influenza Virus Vaccine

Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.

Department Of Veterans AffairsIL, USA

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Sep 8, 2026

36E79726R0035

Closed

Federal1

6505--Glipizide Tablets

The Department of Veterans Affairs, through the National Acquisition Center, plans to award a single indefinite-delivery, indefinite-quantity contract for Glipizide Tablets to ensure an uninterrupted supply for VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center facilities. The contract will have a one-year base period with four one-year option periods, and the product will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under a unique NDC number assigned exclusively to them, with their label being the only label on the product; VA labeling must be able to securely adhere over the contractor’s label without overlapping or covering existing labels. All tablets must be packaged in unit-of-use bottles with specific physical requirements: cylindrical shape, minimum 120cc volume, 5.75-inch circumference, and a label space of 5.25 x 2 inches with an additional 0.5 inches reserved for barcodes and expiration dates. Bottles must include a safety cap that can be converted to a non-safety cap and must not exceed the bottle’s diameter. The solicitation will be issued electronically on or about July 27, 2026, with responses due by August 10, 2026, under FAR Part 12 as a commercial item procurement. The NAICS code is 325412, and only electronic access via SAM.gov is available—no paper copies or phone requests will be honored. Estimated annual demand includes multiple package sizes for both 5mg and 10mg tablets, with bottle volumes of 90, 180, and 360 counts for unit-of-use packaging, and bulk options of 500 or 1,000 tablets for non-unit-of-use needs, totaling over 300,000 bottles annually. The primary point of contact is Contract Specialist Deb Fassl, reachable via email at [email hidden], and potential offerors must monitor SAM.gov regularly for amendments or updates. All responsible sources are invited to submit offers, and submissions received on time will be considered without restriction.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Jul 13, 2026

36E79726R0031

Closed

Awarded4

6505--Melatonin Tablets Effective 09/15/26 - 09/14/27

The Department of Veterans Affairs, through its National Acquisition Center, has awarded a requirements contract for the supply of melatonin tablets and capsules in 1mg, 3mg, and 5mg dosages with a one-year base period and four one-year option periods, effective from September 15, 2026, to September 14, 2027. The contract, issued under solicitation number 36E79726R0015, is an unrestricted commercial item procurement governed by FAR Part 12 and awarded using the Lowest Price Technically Acceptable methodology, where technical acceptability is a pass/fail threshold and award is determined solely by the lowest evaluated price. The supply is intended to meet the needs of multiple federal agencies including the VA, DoD, BOP, IHS, and FHCC, with estimated annual usage of 35,394 bottles of 1mg, 1,363,153 bottles of 3mg, and 439,142 bottles of 5mg melatonin tablets. Packaging and labeling requirements are strictly defined: products must be in plastic, child-proof safety-cap bottles of 60 or 90 count with a minimum 120cc volume and cylindrical shape meeting specific dimensional thresholds; each bottle must carry a unique 11-digit NDC number, FDA-compliant labeling per GS1 and HIBCC standards, and a legible barcode on the immediate container with a Data Matrix 2D barcode on the lowest saleable package to meet DSCSA requirements. Labels must allow VA over-labeling, maintain visibility of expiration and lot numbers, and include human-readable numbers adjacent to barcodes for BCMA system fallback. All manufacturing must comply with current Good Manufacturing Practices (cGMP), and offerors must provide stability testing certification. The contract mandates submission of physical samples for evaluation and requires active SAM.gov registration with correct UEI and CAGE codes. Payments will flow through designated government Prime Vendors such as McKesson and Cardinal Health, with no direct payment from the government, and assignment of payment rights is prohibited. Subcontracting plans are required if the contract value exceeds $900,000, and compliance with VA, FDA, and federal regulations is mandatory throughout performance. The contracting officer for this award is Deborah Fassl, based in Hines, Illinois, and offers were due by March 26, 2026.

Department Of Veterans AffairsIL, USA

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79726R0015

Awarded

Federal2

6505--Acamprosate CA EC Tablets

The solicitation for Acamprosate CA EC Tablets under solicitation number 36E79726R0021, issued by the Department of Veterans Affairs through its Nac Pharmaceuticals office in Hines, Illinois, seeks commercial pharmaceutical supplies under a Lowest Price Technically Acceptable (LPTA) procurement strategy. The contract requires the delivery of 33,661 bottles of 333mg extended-release tablets per base year, with four one-year option periods of equal volume, all subject to strict pharmaceutical and packaging standards. The product must be manufactured and packaged in compliance with FDA regulations, USP-NF monographs, current Good Manufacturing Practices (cGMP), and the Drug Supply Chain Security Act (DSCSA), including serialization via a two-dimensional GS1 Data Matrix bar code at the lowest saleable package level and a linear GS1-128, HIBCC, or UPC bar code complying with ANSI/ISO/IEC Grade C quality standards on the unit-of-use bottle. Packaging must exclude glass, feature a child-resistant safety cap, accommodate automated dispensing systems, provide sufficient space for VA labeling over the contractor’s label, and ensure machine-readable bar codes are presented in ladder orientation with adequate quiet zones and human-readable NDC adjacent to the barcode. The contract incorporates standard Federal Acquisition Regulation clauses with VA-specific deviations, including restrictions on subcontractor sales, mandatory business ethics and whistleblower protections, prohibitions on restrictive confidentiality agreements, and requirements regarding contractor responsibility, suspension, debarment, and inverted domestic corporations. A VA-specific small business subcontracting plan is mandatory for contracts exceeding $700,000, and contractors must affirm small business status, UEI and CAGE codes, and manufacturer commitment if not the producer. Proposals must be submitted by May 28, 2026, via email in PDF or Word format with a signed SF-1449, and must include NDCs, facility FEI numbers, and compliance with DSCSA and FDA requirements. Evaluation is strictly based on lowest price among technically acceptable offers, with no discussions anticipated, and all items are subject to inspection at the source facility and acceptance at the delivery destination. The government will process payments through the VA Prime Vendor program, and all performance must occur at FDA-registered facilities, with deliveries governed by FOB origin or destination terms as specified in individual orders. No contract value is yet determinable, as pricing data must be provided by offerors.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted May 14, 2026

36E79726R0021

Closed

Federal4

6505--Amiodarone HCL Tablets

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal for a one-year contract with up to four one-year options to supply Amiodarone Hydrochloride (HCL) Tablets. This procurement supports multiple federal healthcare entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The awarded contract will ensure a continuous supply of the product, distributed through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. The solicitation requires that the drug be provided under the exact product name with a unique National Drug Code (NDC) specific to the offeror, and that labeling must adhere to strict requirements, including security of labels and specific safety packaging standards for unit-of-use bottles. The contract will cover three specific items: 100 mg Amiodarone HCL tablets in 30-count bottles, 200 mg tablets in both 60-count bottles and 500-count bulk packaging, with estimated annual usage totaling over 182,000 bottles across all sizes. The solicitation will be issued electronically around March 11, 2026, with proposals due by March 19, 2026. Interested offerors must monitor SAM.gov for updates and submit their proposals electronically, as no paper copies will be provided. The procurement falls under NAICS code 325412 and is managed by Contract Specialist Deb Fassl, who serves as the primary contact for questions and communications regarding this opportunity.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Apr 7, 2026

36E79726R0014

Closed

Awarded2

6505--Influenza Virus Vaccine 2026-2027 Flu Season Line Items 1, 3, 5, 7, and 8

The Department of Veterans Affairs, through the National Acquisition Center in Hines, Illinois, has awarded contracts for the procurement of Influenza Virus Vaccines for the 2026-2027 flu season under solicitation 36E79725R0064. The total combined value of the awards is approximately 39.6 million dollars, split between two primary contractors. Seqirus USA Inc. was awarded contract 36E79726D0010 for 30,925,399.40 dollars covering line items 2, 4, 6, and 9, while Sanofi Pasteur Inc. was awarded contract 36E79726D0009 for 8,668,211.16 dollars covering line items 1, 3, 5, 7, and 8. Both awards were finalized on December 15, 2025. The procurement falls under NAICS code 325412 for biological product manufacturing and Product Service Code 6505. While specific delivery schedules and technical specifications are not detailed, the scope involves the supply and delivery of seasonal vaccines, which inherently require strict cold chain preservation and pharmaceutical packaging standards. The primary point of delivery and performance is located in Hines, Illinois, with the contracting office managed by Contracting Officer Deb Fassl. The contracts are structured around specific line items to ensure a distributed supply of vaccines for the designated flu season.

Department Of Veterans AffairsIL, USA$39.6M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0064

Awarded

Awarded3

6505--Bupropion HCL 12HR SA Tablets Effective 05/16/2026 - 05/15/2027

The contract pertains to the procurement of Bupropion Hydrochloride 12-hour Sustained Action Tablets, intended to serve the needs of the Department of Veterans Affairs and other federal agencies such as the Department of Defense, Bureau of Prisons, Indian Health Service, and the Federal Health Care Center. The solicitation, numbered 36E79725R0065, was issued by the VA National Acquisition Center and is scheduled for release around November 4, 2025, with a deadline for responses set for November 18, 2025. The contract will be awarded for an initial one-year period, with four additional one-year options, allowing for extended supply if needed. The procurement emphasizes detailed packaging and labeling requirements, with specific instructions for submitting comprehensive pricing for all line items across the base and option years. The contract aims to secure a reliable supply of the medication in various dosages and packaging sizes, with the award to be made on an aggregate basis for all line items. The designated point of contact for inquiries is Contract Specialist Deborah S Fassl, based in Hines, Illinois. The procurement process is conducted electronically, ensuring transparency and accessibility for qualified offerors.

Department Of Veterans AffairsIL, USA$8.3M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0065

Awarded

Awarded1

6505--RSV Vaccine Effective 10/01/2025-09/30/30

The contract pertains to the procurement of the RSV Vaccine under solicitation number 36E79725R0043, posted on June 16, 2025, with a response deadline of July 1, 2025. It is managed by Nac Pharmaceuticals, an organization based in Hines, Illinois, and is associated with the NAICS code 325412, which covers pharmaceuticals and medicines. The contract is intended to support the agency's efforts to acquire the RSV vaccine, likely for healthcare or vaccination programs, although specific performance locations are not detailed. Interested parties can contact the designated Contract Specialist, Deborah S Fassl, via email for further information or clarifications. The opportunity is accessible through the SAM.gov platform, providing a comprehensive overview of the solicitation details.

Department Of Veterans AffairsIL, USA$86.7M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0043

Awarded Aug 25, 2025

Awarded1

6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Effective 10/06/2025-10/05/2026

The contract titled "6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets" involves the Department of Veterans Affairs awarding AVKARE LLC a contract, with a value of $9,977,967.85, for the supply of Emtricitabine/Tenofovir Disoproxil Fumarate Tablets. The contract period is from October 6, 2025, to October 5, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. The award notice was posted on June 30, 2025, and the award date is June 27, 2025. This is an active contract under solicitation number 36E79725R0035, awarded by the NAC Pharmaceuticals division of the Department of Veterans Affairs. The awarded company, AVKARE LLC, is based in Pulaski, Tennessee. The primary point of contact for this contract is Deb Fassl, Contract Specialist, based in Hines, Illinois. The contract is associated with the federal classification code 6505, which covers drugs and biologicals. There are no specified set-aside types or restrictions indicated for this contract, and no detailed place of performance has been disclosed. The contract award information can be accessed via the SAM.gov online portal for further details.

Department Of Veterans AffairsIL, USA$10M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0035

Awarded Jun 27, 2025